Neuroendocrine Tumors Market Segmentation Detailed Study With Forecast Up To H2 2017

Overview

Neuroendocrine tumor begins in the hormone-producing cells of the body’s neuroendocrine system, which is made up of cells that are a cross between traditional endocrine cells (or hormone-producing cells) and nerve cells. Symptom includes hyperglycemia, diarrhea, loss of appetite/weight loss, thickening or lump in any part of the body, jaundice, headache, anxiety and gastric ulcer disease. Treatments include surgery, radiation therapy and chemotherapy.

 Click here for sample report @ http://www.wiseguyreports.com/sample-request/2740082-neuroendocrine-tumors-pipeline-review-h2-2017

Report Highlights

The Pharmaceutical and Healthcare latest pipeline guide Neuroendocrine Tumors - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Neuroendocrine Tumors (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Neuroendocrine Tumors (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Neuroendocrine Tumors and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 2, 29, 25, 2, 6, 3 and 1 respectively. Similarly, the Universities portfolio in Phase II and Phase I stages comprises 2 and 2 molecules, respectively.

 Major Scope of the report:

- The pipeline guide provides a snapshot of the global therapeutic landscape of Neuroendocrine Tumors (Oncology). 
- The pipeline guide reviews pipeline therapeutics for Neuroendocrine Tumors (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources. 
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. 
- The pipeline guide reviews key companies involved in Neuroendocrine Tumors (Oncology) therapeutics and enlists all their major and minor projects. 

Table of Contents 

Table of Contents 2 
Introduction 5 
Neuroendocrine Tumors - Overview 6 
Neuroendocrine Tumors - Therapeutics Development 7 
Neuroendocrine Tumors - Therapeutics Assessment 18 
Neuroendocrine Tumors - Companies Involved in Therapeutics Development 30 
Neuroendocrine Tumors - Drug Profiles 52 
Neuroendocrine Tumors - Dormant Projects 444 
Neuroendocrine Tumors - Discontinued Products 446 
Neuroendocrine Tumors - Product Development Milestones 447 
Appendix 458

List of Tables 
Number of Products under Development for Neuroendocrine Tumors, H2 2017 
Number of Products under Development by Companies, H2 2017 
Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017 
Number of Products under Development by Companies, H2 2017 (Contd..2), H2 2017 
Number of Products under Development by Universities/Institutes, H2 2017 

 .Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2740082-neuroendocrine-tumors-pipeline-review-h2-2017

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.